We are live on ! Find out more
MLICM

Metropolitan Life Insurance Company (MetLife) Portfolio holdings

AUM $328M
1-Year Est. Return 9.77%
This Fund
S&P 500
This Quarter Est. Return
+0.76%
1 Year Est. Return
+9.77%
3 Year Est. Return
+50.33%
5 Year Est. Return
+74.21%
10 Year Est. Return
+345.05%
AUM
$6.9B
AUM Growth
-$199M
Cap. Flow
-$157M
Cap. Flow %
-2.27%
Top 10 Hldgs %
24.04%
Holding
3,083
New
373
Increased
407
Reduced
1,584
Closed
241

Sector Composition

Rank Sector Weight
1 Technology 23.96%
2 Healthcare 12.46%
3 Financials 12.39%
4 Consumer Discretionary 12.33%
5 Communication Services 9.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AGL icon
2451
Agilon Health
AGL
$1.49B
$114K ﹤0.01%
175
+42
+32% +$35.9K
DYN icon
2452
Dyne Therapeutics
DYN
$4.85B
$114K ﹤0.01%
7,037
-2,180
-24% -$38.6K
OMF icon
2453
OneMain Financial
OMF
$7.51B
$114K ﹤0.01%
2,065
+234
+13% +$13.6K
WLDN icon
2454
Willdan Group
WLDN
$1.29B
$114K ﹤0.01%
3,208
MOV icon
2455
Movado Group
MOV
$796M
$114K ﹤0.01%
3,623
-1,211
-25% -$38.7K
HTB
2456
HomeTrust Bancshares
HTB
$837M
$114K ﹤0.01%
4,077
-1,882
-32% -$51.7K
APEI icon
2457
American Public Education
APEI
$828M
$114K ﹤0.01%
4,454
PTVE
2458
DELISTED
Pactiv Evergreen Inc. Common stock
PTVE
$114K ﹤0.01%
9,107
-4,338
-32% -$58.9K
UFCS icon
2459
United Fire Group
UFCS
$1.38B
$114K ﹤0.01%
4,930
-2,050
-29% -$51.2K
VKTX icon
2460
Viking Therapeutics
VKTX
$3.84B
$114K ﹤0.01%
18,079
+8,520
+89% +$52.6K
LAB icon
2461
Standard BioTools
LAB
$294M
$113K ﹤0.01%
17,202
-6,903
-29% -$45.4K
GTHX
2462
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$113K ﹤0.01%
8,442
-2,645
-24% -$43.1K
TIL icon
2463
Instil Bio
TIL
$49.3M
$113K ﹤0.01%
316
-5
-2% -$1.87K
ALNT icon
2464
Allient
ALNT
$1.86B
$113K ﹤0.01%
3,601
CONN
2465
DELISTED
Conn's Inc.
CONN
$113K ﹤0.01%
4,929
GRTS
2466
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$112K ﹤0.01%
10,414
-235
-2% -$2.14K
HOFT icon
2467
Hooker Furnishings Corp
HOFT
$158M
$112K ﹤0.01%
4,163
DLB icon
2468
Dolby
DLB
$5.84B
$112K ﹤0.01%
1,276
-52
-4% -$5.04K
SMBK icon
2469
SmartFinancial
SMBK
$899M
$112K ﹤0.01%
4,329
MAX icon
2470
MediaAlpha
MAX
$813M
$112K ﹤0.01%
5,986
INVE icon
2471
Identive
INVE
$64.1M
$111K ﹤0.01%
5,908
CURO
2472
DELISTED
CURO Group Holdings Corp.
CURO
$110K ﹤0.01%
6,332
CZNC icon
2473
Citizens & Northern Corp
CZNC
$466M
$110K ﹤0.01%
4,344
NKTX icon
2474
Nkarta
NKTX
$165M
$109K ﹤0.01%
3,933
-2,370
-38% -$75.1K
SIRI icon
2475
SiriusXM
SIRI
$9.43B
$109K ﹤0.01%
1,793
-71
-4% -$4.46K

Similar funds

Metropolitan Life Insurance Company (MetLife)'s Q3 2021 Portfolio in Review

As of Q3 2021, Metropolitan Life Insurance Company (MetLife) held 3,083 positions worth $6.9B, down 2.8% from $7.1B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Metropolitan Life Insurance Company (MetLife)'s Q3 2021 filing shows 373 new, 407 increased, 1,584 reduced and 241 closed positions. Its largest new stake was Alphabet (Google) Class C: 878,340 shares worth $117M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $17.5M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.

  • Metropolitan Life Insurance Company (MetLife)'s largest Q3 2021 buy was Alphabet (Google) Class C: 878,340 shares worth $117M.
  • Metropolitan Life Insurance Company (MetLife) added most to iShares Russell 1000 Growth ETF in Q3 2021, an estimated $17.3M increase.
  • Metropolitan Life Insurance Company (MetLife)'s biggest Q3 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $17.5M.
  • Metropolitan Life Insurance Company (MetLife) fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $4.87M.
  • Metropolitan Life Insurance Company (MetLife)'s ten largest holdings make up 24% of its $6.9B portfolio in Q3 2021.
  • Metropolitan Life Insurance Company (MetLife) opened 373 new positions and closed 241 in Q3 2021.
  • Metropolitan Life Insurance Company (MetLife)'s portfolio value fell 2.8% quarter-over-quarter to $6.9B.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q3 2021, filed 15 Nov 2021.